chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pfizer vaccine was administered outside of clinic- reported by patient- ? NO LOT NUMBER WERE SUPPLIED   CHRONIC HYPOXEMIC RESPIRATORY FAILURE 6/10/2022 ACUTE RENAL FAILURE, UNSPECIFIED
2 month old child given flu vaccine  on 01/06/21.  It was discovered on 10/08/21 when VFC nurse was documenting vaccines in hospital. Child's mother was contacted and reports no adverse effects.
After first injection 10/08 - fatigue, muscle stiffness and weakness. CPK increased to 2000
No additional AE; patient that received their 3rd dose of GARDASIL 9 today 28JUL2022. Dose was given 4 months late.; This spontaneous report was received from a medical assistant and refers to a 28-year-old, non-pregnant female patient. Her concomitant medications, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported.  On 28-JUL-2022, the patient was vaccinated with 3rd dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered (dose, lot #, expiry date, and route of administration were not provided) for prophylaxis, which was reported to be administered as 4 months late (Inappropriate schedule of product administration). No additional adverse event was provided. administered on 28-JUL-2022 in the right arm. No other vaccines were administered on the same day or within 4 weeks. The patient did not have an illness on the day of vaccination.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN GLARGINE (LANTUS) and INSULIN LISPRO (HUMALOG) for Diabetes, IRBESARTAN (AVAPRO) and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with AMOXICILLIN at a dose of 1 dosage form and CODEINE at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (sore arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-067216, MOD-2021-067216 (Patient Link).
minor pain in the arm when pressed on it; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (minor pain in the arm when pressed on it) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (minor pain in the arm when pressed on it). The patient was treated with ACETAMINOPHEN for Pain in arm, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (minor pain in the arm when pressed on it) outcome was unknown.            Concomitant medications was not specified.  Treatment information also included use of ICE.   This case was linked to MOD-2021-370431 (Patient Link).
Patient briefly fainted immediately following injection. Loss of consciousness was less than 5 seconds. Patient was placed laying down with feet raised. Fan was used to cool patient. Patient was given water. Patient quickly recovered. When patient fell, she was partially caught by Grandmother, so no further injury was sustained.
pt recvd vax 8APR94 & devel high fever & convuls; treated @ ER; MD state react to MMR; 13 days later devel generalized rash that lasted 3 days;
Itchy, red, blotchy rash on trunk, arms and upper thighs.
No additional AE details; TE evaluation states vaccines have been administered; This spontaneous report was received from a medical assistant and refers to unspecified number of patients. The patients' medical history, concurrent conditions were not reported and concomitant therapies were not reported.  On an unknown date, the patients were vaccinated with improperly stored doses of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (lot # U025790, expiration date: 19-AUG-2023, lot # U029496 with expiration date on 21-SEP-2023) administered for prophylaxis (dose and route of administration were not provided).  The vaccines underwent temperature excursion of -14 degrees Celsius up to -10 degrees Celsius during a time frame of 3 hours; -10 degrees Celsius up to 8 degrees Celsius during a time frame of 1 hour and 30 minutes. No adverse event was reported.  This is one of several reports from the same reporter.  Follow-up information has been received from the medical assistant on 24-MAY-2022, referring to a 4-year-old (also reported as 5-year-old, discrepant information) female patient.   On 25-MAR-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) administered subcutaneously (SQ) as prophylaxis (dose and anatomical site of vaccination were not reported; lot number U025790 has been verified to be valid, expiration date reported and established as 19-AUG-2023).   The patient's identifiers were missing in the initial report.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2205USA003614: US-009507513-2205USA007821: US-009507513-2205USA007847: US-009507513-2205USA007852:
Left Clinic and felt fine rest of day. Arm soreness increased as the day went on. Woke from a sound sleep to the sensation of the whole room spinning so bad that I could not walk across the room, was throwing up and very disoriented. I was unable to sit anyway but upright and still had dizziness then. Had a appointment with GP the next morning and was told to go to the ER for treatment. By then, I was stil so dizzy it was debilitating, also could not handle light, sound and smell, headache and my neck hurt. While in the ER, my back also started to hurt and even with the medications they gave me, I felt dizzy most of the time I was there. Was given medication for dizziness and nausea to take home. I continued to have symptoms almost all of those symptoms for the next 2 days severely, along with excessive sleeping. It is now 1 week later and I still have some dizziness off and on especially if I move my head too much, I have a persistant headache and I feel tired.   Medications in hospital: IV, sodium chloride .9%, promethazine (Phenergan), meclizine (Antivert), diphenhydramine (Benadryl), diazepam (Valium) and acetaminophen (Tylenol) Meds to take home: Meclizine 25mg, Ondansetron ODT 4mg
Incident occurred from possible inviable covid-19 pfizer-purple dose (booster) being administered to the patient. Patient reported no adverse events other than typical ones from covid vaccine. Patient accepted offer to come back to receive a replacement booster dose.
Localized reaction both arms left arm varicella, right arm MMR. Both given SQ, localized red rash. Ice to left arm. Clarinex 5mg given PO also states feeling flushed.
I was out of the country visiting , I felt like my allergies were bothering some. Itchy watery eyes, runny nose, scratchy throat, slight cough. I had to test to get on the plane to come home as I had been exposed to COVID-19 someone in our group. I tested positive and had to quarantine for seven before flying back home. I do feel fine.
patient was administered vaccine after the 30 day beyond use date; No adverse event; patient was administered vaccine after the 30 day beyond use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient was administered vaccine after the 30 day beyond use date), PRODUCT STORAGE ERROR (patient was administered vaccine after the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 46-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7144B) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 21-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient was administered vaccine after the 30 day beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (patient was administered vaccine after the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient was administered vaccine after the 30 day beyond use date), PRODUCT STORAGE ERROR (patient was administered vaccine after the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patient was administered vaccine after the 30 day beyond use date) and PRODUCT STORAGE ERROR (patient was administered vaccine after the 30 day beyond use date).    No concomitant medications were reported.  Individual vial was opened.  Vial size was reported as 2.5 ml.  The vial was initially stored in the refrigerator on 20-Sep-2022.  The vial did not undergo any temperature excursions.  No treatment medications were reported.
Information has been received from a nurse practitioner concerning a 6 year old female who on 10/23/1998 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck).  The nurse reported that on 04/29/2004 the patient developed chickenpox characterized by about 50 lesions on her body and about three lesions in her mouth.  Unspecified medical attention was sought with unspecified treatment required.  At the time of this report, the outcome was unknown.  The nurse also reported that another patient developed breakthrough chickenpox after being vaccinated with varicella virus vaccine live (Oka/Merck) (WAES 0405USA00765).  Additional information has been requested.
pain in the left arm; it was strange; Pain in elbow; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the left arm), FEELING ABNORMAL (it was strange) and ARTHRALGIA (Pain in elbow) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 11J20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic, Blood pressure high and Allergy. Concomitant products included ALPRAZOLAM (XANAX) for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in the left arm), FEELING ABNORMAL (it was strange) and ARTHRALGIA (Pain in elbow). At the time of the report, PAIN IN EXTREMITY (pain in the left arm) had resolved, FEELING ABNORMAL (it was strange) outcome was unknown and ARTHRALGIA (Pain in elbow) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details was not reported by the reporter. Patient took High blood pressure pills and allergy medication. Patient took Xanax occasionally. Patient is Pre-Diabetic controlling with diet and exercise.   This case was linked to MOD-2022-460646 (Patient Link).
patient received MMR vaccine on 4-30-19 at office visit. patient called office in am on 5-13-19 with chills and rash on chest back and face.
Immediate blurred vision, bilateral conjunctivitis, cough, elevated pulse and B/P, later in evening with fever, chills, frequent urination, flu like illness. difference in taste buds.  Symptoms almost disappeared within 24 hours.
FLU VACCINE SITE - SHOULDER BURSITIS , UNABLE TO ROTATE LEFT ELBOW , RADIATING PAIN ANTERIO SHOULDER, PAIN RADIATIONG TO LEFT LOWER ARM WITH EXRTERNAL AND INTERNAL ROTATION OF LEFT ELBOW
2 days post vax pt exp intermittant episodes of poss disorientation staring into space;  head cold 2 days later;
This is all the information I have from the reporting provider:  Tingling lips after Moderna Vaccine #1...  Normal face.  02 sat 97%   HR 78 Resolved with Reassurance .
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE TRANSIENT CEREBRAL ISCHEMIA ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY
headache lasted 2 weeks. Moved down into neck near end of 2 weeks.
experiencing tingling in legs and problem getting up with muscles; problem getting up with muscles; Sore arm; flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PARAESTHESIA (experiencing tingling in legs and problem getting up with muscles), MOBILITY DECREASED (problem getting up with muscles) and MYALGIA (Sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 038K20A) for COVID-19 vaccination.     Concomitant products included OMEPRAZOLE for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms) and MYALGIA (Sore arm). On 02-Apr-2021, the patient experienced PARAESTHESIA (experiencing tingling in legs and problem getting up with muscles) and MOBILITY DECREASED (problem getting up with muscles). On 27-Feb-2021, INFLUENZA LIKE ILLNESS (flu like symptoms) and MYALGIA (Sore arm) had resolved. At the time of the report, PARAESTHESIA (experiencing tingling in legs and problem getting up with muscles) and MOBILITY DECREASED (problem getting up with muscles) had not resolved.            No treatment details were reported.
Patient's mother called the Health Dept. at 8:00 AM on 5-20-13 to report that she had taken patient to facility because of a reaction she had from her immunizations. The Health Department had held an immunization clinic at patient's school on 05-16-2013. At that clinic, patient received T-dap via intramuscular injection in her right deltoid, varicella via subcutaneous injection in the back of her right arm and Menactra via intramuscular injection in her left arm. Patient's mother reported that she noticed that patient's right arm was warm to the touch and had redness, and swelling Friday evening. She also noticed that she had bruising to both deltoids. She took patient to facility where they circled the area. Later, they returned to facility and the area had grown 2". Patient was placed on Augmentin and Benadryl. She was instructed to return to facility in 5 days if it was not getting better. Patient's mother reported that facility did not think that it was the Tdap because the location of the redness, swelling and heat was coming from the back of her right arm. Her mother also said that the medicine seemed to be working because the area of redness and swelling was getting smaller.
Hives around eyes for a few hours on 12/03 and Hives on feet for a few hours on 12/04.  This was the same reaction as when he had influenza 2 months prior per child's mother.
LEFT ARM SORE AT INJECTION SITE. PATIENT STATES THE SORENESS LIMITS HER LEFT ARM MOVEMENT.
This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of THROMBOSIS (blood clot in each lung) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included CALCIUM FRUCTOBORATE, CHONDROITIN SULFATE SODIUM, GLUCOSAMINE HYDROCHLORIDE, HYALURONIC ACID (MOVE FREE JOINT HEALTH) for Joint disorder NOS, MINERALS NOS, VITAMINS NOS (ONE A DAY [MINERALS NOS;VITAMINS NOS]) for an unknown indication. On 21-Jan-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021 at 9:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced THROMBOSIS (blood clot in each lung) (seriousness criteria medically significant and life threatening). On 28-Feb-2021 at 6:00 PM, the patient experienced DYSPNOEA (shortness of breath). At the time of the report, THROMBOSIS (blood clot in each lung) outcome was unknown and DYSPNOEA (shortness of breath) had resolved with sequelae. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, Computerised tomogram: blood clot (abnormal) Blood clot in both lung. On 21Jan2021, patient had received the first dose of Moderna Covid-19 vaccine and about 4-5 days later,  he began to noticed that his breathing was labored.  At the time of the report, the patient did not think much about the labored breathing since he was older in age and thought it was due to exercise. Patient received second dose of Moderna COVID-19 Vaccine on 18-Feb-2021 and he reported that his breathing became more laboring where he needed to stop walking to catch his breath. He had 2 scan which revealed that he have a blood clot at each lung and he was prescribed Xarelto 15 mg twice a day, then he will begin Xarelto 20mg once a day on 20-MAY-2021. Patient is on Kirkland C  500mg   as a concomitant medication as well. Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Significant FU- outcome of the event.
Severe headache started about 2 hours after the shot and continued almost without stop for about the first 3 months, sometimes lessening to moderate but never going away even when asleep (although they did not prevent me from sleeping). Since about early September the headaches become less severe and intermittent - sometimes a day or two goes by without very much pain.  At the request of my primary care physician, I saw neurologist on Oct. 20, 2021. The neurologist determined that I had no underlying condition, such as a brain tumor, and said I had "chemical meningitis" caused by the vaccine. He had no treatment to offer at this time. (That's what my PCP also said - "I don't know what to do for you.") The neurologist also said my reaction to a second shot would probably be much worse.
Tinnitus condition worsened dramatically after 1st covid vaccine. Condition has not improved.
The vaccinee was a hemodialysis pt. On unspecified dates, the vaccinee received his 1st, 2nd, 3rd and 4th 40 mcg injections of Engerix-B. He was found to be a non-responder on an unspecified date, following his 4 injection with Engerix-B. As of 3/15/02, the outcome of the event was unknown.
Sore arm for 48h; constant tired for a week after vaccination; After a week, the injection area started turning to red rash; After 13 days, the color gets darker red with a bit itchy. After 10 days of vaccination, I had severe abdominal pain when my period came.
pt recvd vax 17MAY94; febrile on 18MAY; 19MAY was 100.3 R & screamed noon to 4PM; also had baby food banas for 1st time; when burped well-did fine;
Developed wheezing and difficulty breathing after vaccines given.  Improved with oral steroids and Epinephrine injection.
got a flu shot recently and ended up with full blown eczema on her forearms after this.; Initial information received on 25-Oct-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp via specialty pharmacy case.   This case involves Adult female patient (129.27 kg) who got a flu shot (Influenza Vaccine) recently and ended up with full blown eczema on her forearms after this.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Drug allergy with DOXYCYCLINE HYCLATE, DEMEROL, PENICILLIN VK, BENADRYL, ZYRTEC, SULFAMETHOXAZOLE, CEFUROXIME and Latex allergy.   On an unknown date, the patient received a dose of suspect Influenza Vaccine by unknown manufacturer (strength, formulation, dose, route, batch number and expiry date: unknown) in unknown administration site for prophylactic vaccination.  On an unknown date the patient got a flu shot recently and ended up with full blown eczema on her forearms after this. (eczema) (unknown latency).  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (got a flu shot recently and ended up with full blown eczema on her forearms after this.).  At time of reporting, the outcome was Unknown for the event got a flu shot recently and ended up with full blown eczema on her forearms after this..
Had a mild allergic reaction,  face turned red under the eyes and on the nose and cheeks within about 10 minutes after receiving vaccination.  Administered 50mg diphenhydramine orally.  Symptoms remained the same for about 20 minutes then started lessening.  After about 45 minutes from time of administration of vaccine symptoms were nearly resolved and patient was allowed to go home with instructions to call 911 or the pharmacy if symptoms returned and difficulty breathing occurred.  No further response from patient.
Patient rec'd immunizations at 2pm and when he woke from nap at 4:30pm he was "blotchy" on stomach, back, cheek and back of head. Not raised or bumpy. Gave BENADRYL, he cleared up, no more problems.
This spontaneous report as received from a registered nurse refers to two patients of unknown age and gender. On 01-MAY-2014 the patients received a dose of (Oka/Merck) PROQUAD (Lot #, 0.5ml dose, subcutaneous route) that were improperly stored. Concomitant medications were not reported. All doses were administered according to the prescribing information. No adverse event reported. This case is linked to MARRS 1405USA003236. Additional information has been requested.